Obinutuzumab in Lupus Nephritis (REGENCY trial) | NEJM
2:09
YouTubeNEJM Group
Obinutuzumab in Lupus Nephritis (REGENCY trial) | NEJM
For patients with lupus nephritis, a recent phase 2 trial showed that the addition of obinutuzumab to standard therapy was associated with a significantly better renal response than placebo. Findings of the REGENCY phase 3 trial are summarized in a new Quick Take video. Read the full trial results: https://nej.md/3Eq6gxV #nephrology # ...
已浏览 2434 次8 个月之前
Obinutuzumab Uses
The OLYMP-1 trial: efficacy and safety of obinutuzumab monotherapy as a first-line treatment for MZL
2:03
The OLYMP-1 trial: efficacy and safety of obinutuzumab monotherapy as a first-line treatment for MZL
YouTubeVJHemOnc – Video Journal
已浏览 3 次5 个月之前
Obinutuzumab in Lupus Nephritis - REGENCY - Prof. Dr. Brad Rovin, Prof. Dr. Ana Malvar
50:54
Obinutuzumab in Lupus Nephritis - REGENCY - Prof. Dr. Brad Rovin, Prof. Dr. Ana Malvar
YouTubeMARKUS at HOMe
已浏览 942 次7 个月之前
Obinutuzumab Mechanism of Action: Treating Lupus Nephritis
4:41
Obinutuzumab Mechanism of Action: Treating Lupus Nephritis
YouTubePharmacology Insights
已浏览 41 次1 个月前
热门视频
6-year results of CLL14: venetoclax-obinutuzumab for previously untreated CLL
5:59
6-year results of CLL14: venetoclax-obinutuzumab for previously untreated CLL
YouTubeVJHemOnc – Video Journal
已浏览 2185 次2023年6月14日
Ravi Vij & Dr. Nitin Jain Discuss AMPLIFY: Acalabrutinib + Venetoclax + Obinutuzumab in CLL
21:53
Ravi Vij & Dr. Nitin Jain Discuss AMPLIFY: Acalabrutinib + Venetoclax + Obinutuzumab in CLL
YouTubeMyCancerHaven for Patients
已浏览 69 次5 个月之前
The CRISTALLO study: obinutuzumab combined with venetoclax in previously untreated CLL
2:13
The CRISTALLO study: obinutuzumab combined with venetoclax in previously untreated CLL
YouTubeVJHemOnc – Video Journal
已浏览 451 次11 个月之前
Obinutuzumab Side Effects
The potential of triplet regimens combining BTKis with venetoclax and obinutuzumab in CLL
1:25
The potential of triplet regimens combining BTKis with venetoclax and obinutuzumab in CLL
YouTubeVJHemOnc – Video Journal
已浏览 70 次2024年10月24日
The triple combination of venetoclax-ibrutinib-obinutuzumab prolongs PFS compared to venetoclax-...
4:39
The triple combination of venetoclax-ibrutinib-obinutuzumab prolongs PFS compared to venetoclax-...
YouTubeecancer
已浏览 18 次3 个月之前
ReVenG trial: safety & efficacy of venetoclax plus obinutuzumab retreatment in patients with R/R CLL
1:53
ReVenG trial: safety & efficacy of venetoclax plus obinutuzumab retreatment in patients with R/R CLL
YouTubeVJHemOnc – Video Journal
已浏览 104 次5 个月之前